BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3053436)

  • 1. A comparative study of 50% alcohol and ethanolamine oleate for oesophageal sclerotherapy.
    Vij JC; Kumar N; Kumar A; Anand BS; Broor SL
    Indian J Gastroenterol; 1988 Oct; 7(4):211-3. PubMed ID: 3053436
    [No Abstract]   [Full Text] [Related]  

  • 2. Ethanolamine oleate for esophageal varices.
    Med Lett Drugs Ther; 1989 Nov; 31(804):99-100. PubMed ID: 2682155
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative effects of 5% ethanolamine oleate versus 5% sodium morrhuate for sclerotherapy of oesophageal varices.
    Kitano S; Wada H; Yamaga H; Hashizume M; Koyanagi N; Iwanaga T; Iso Y; Sugimachi K
    J Gastroenterol Hepatol; 1991; 6(5):476-80. PubMed ID: 1932669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethanolamine oleate versus absolute alcohol as a variceal sclerosant: a prospective, randomized, controlled trial.
    Sarin SK; Mishra SP; Sachdev GK; Thorat V; Dalal L; Broor SL
    Am J Gastroenterol; 1988 May; 83(5):526-30. PubMed ID: 3284336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: a nonrandomized study.
    Oho K; Iwao T; Sumino M; Toyonaga A; Tanikawa K
    Endoscopy; 1995 Jun; 27(5):349-54. PubMed ID: 7588347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of elective endoscopic sclerotherapy of hemorrhage from esophageal varices. 2-year follow-up].
    Cabriada J; Orive V; Alzate LF; Arenas JI
    Rev Esp Enferm Apar Dig; 1988 Oct; 74(4 Pt 2):429-34. PubMed ID: 3265215
    [No Abstract]   [Full Text] [Related]  

  • 7. [38 cases of sclerotherapy of esophageal varices].
    Sigiyama K; Li ZL
    Zhonghua Nei Ke Za Zhi; 1985 May; 24(5):263-5, 317. PubMed ID: 3876916
    [No Abstract]   [Full Text] [Related]  

  • 8. Simple endoscopic injection sclerotherapy of oesophageal varices.
    Harris OD; Dickey JD; Stephenson PM
    Aust N Z J Med; 1982 Apr; 12(2):131-5. PubMed ID: 6979997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic injection sclerotherapy for esophageal varices using a transparent hood.
    Horigome H; Nomura T; Nakao H; Kanematsu T; Joh T; Ohara H; Itoh M
    Am J Gastroenterol; 2000 Dec; 95(12):3679-80. PubMed ID: 11151939
    [No Abstract]   [Full Text] [Related]  

  • 10. Trial of sclerosing agents in patients with oesophageal varices.
    Kitano S; Iso Y; Yamaga H; Hashizume M; Higashi H; Sugimachi K
    Br J Surg; 1988 Aug; 75(8):751-3. PubMed ID: 3048533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of endoscopic variceal ligation in prophylactic therapy for bleeding of oesophageal varices: a prospective, controlled trial compared with endoscopic injection sclerotherapy.
    Gotoh Y; Iwakiri R; Sakata Y; Koyama T; Noda T; Matsunaga C; Ogata SI; Ishibashi S; Sakata H; Tsunada S; Fujimoto K
    J Gastroenterol Hepatol; 1999 Mar; 14(3):241-4. PubMed ID: 10197493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injection sclerotherapy for bleeding varices--a review.
    Bhasin DK; Koshy A
    Indian J Gastroenterol; 1985 Jan; 4(1):35-7. PubMed ID: 3881343
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ethanolamine oleate as a sclerosing solution in the therapy of esophageal varices].
    Tsutsumi M; Takada A
    Nihon Rinsho; 1990 Apr; 48(4):713-7. PubMed ID: 2366357
    [No Abstract]   [Full Text] [Related]  

  • 14. Injection sclerotherapy for gastric varices using N-butyl-2-cyanoacrylate and ethanolamine oleate.
    Miyazaki S; Yoshida T; Harada T; Shigemitsu T; Takeo Y; Okita K
    Hepatogastroenterology; 1998; 45(22):1155-8. PubMed ID: 9756025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injection sclerotherapy for bleeding esophageal varices in cirrhotic patients with hepatocellular carcinoma.
    Ng WD; Chan YT; Ho KK; Kong CK
    Gastrointest Endosc; 1989; 35(1):69-70. PubMed ID: 2537777
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical evaluation of endoscopic injection sclerotherapy using N-butyl-2-cyanoacrylate for gastric variceal bleeding.
    Sheikh RA; Trudeau WL
    Gastrointest Endosc; 2000 Jul; 52(1):142-4. PubMed ID: 11012301
    [No Abstract]   [Full Text] [Related]  

  • 17. The value of combined use of N-butyl-2-cyanoacrylate and ethanolamine oleate in the management of bleeding esophagogastric varices.
    Thakeb F; Salama Z; Salama H; Abdel Raouf T; Abdel Kader S; Abdel Hamid H
    Endoscopy; 1995 Jun; 27(5):358-64. PubMed ID: 7588349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative evaluation of sclerosants for esophageal varices: a prospective randomized controlled study.
    Kochhar R; Goenka MK; Mehta S; Mehta SK
    Gastrointest Endosc; 1990; 36(2):127-30. PubMed ID: 2185977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic sclerotherapy in a rat model of esophageal varices.
    Nishida R; Inoue R; Takimoto Y; Hamashima H; Kita T
    Scand J Gastroenterol; 1995 May; 30(5):489-96. PubMed ID: 7638578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological findings in the esophagus after endoscopic sclerotherapy for variceal bleeding.
    Pushpanathan C; Idikio H
    Am J Gastroenterol; 1986 Jan; 81(1):9-13. PubMed ID: 3484607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.